A common variant of CDKN2A (p16) predisposes to breast cancer

被引：61

作者：

Debniak, T

Górski, B

Huzarski, T

Byrski, T

Cybulski, C

Mackiewicz, A

Gozdecka-Grodecka, S

Gronwald, J

Kowalska, E

Haus, O

Grzybowska, E

Stawicka, M

Swiec, M

Urbanski, K

Niepsuj, S

Wasko, B

Gózdz, S

Wandzel, P

Szczylik, C

Surdyka, D

Rozmiarek, A

Zambrano, O

Posmyk, M

Narod, SA

Lubinski, J

机构：

[1] Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada

[2] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland

[3] Dept Canc Immunol, Poznan, Poland

[4] Dept Clin Genet, Bydgoszcz, Poland

[5] Maria Sklodowska Curie Inst, Dept Tumour Biol, Gliwice, Poland

[6] Prophylact & Epidemiol Ctr, Poznan, Poland

[7] Reg Oncol Hosp, Opole, Poland

[8] Reg Oncol Ctr, Krakow, Poland

[9] Reg Oncol Hosp, Olsztyn, Poland

[10] Reg Hosp, Rzeszow, Poland

[11] Holycross Oncol Ctr, Kielce, Poland

[12] Reg Hosp, Bielsko Biala, Poland

[13] Mil Hosp, Warsaw, Poland

[14] Reg Hosp, Lublin, Poland

[15] Reg Oncol Hosp, Zielona Gora, Poland

[16] Reg Hosp, Lodz, Poland

[17] Reg Oncol Hosp, Bialystok, Poland

来源：

JOURNAL OF MEDICAL GENETICS | 2005年 / 42卷 / 10期

关键词：

D O I：

10.1136/jmg.2005.031476

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Background: A common missense variant of the CDKN2A gene (A148T) predisposes to malignant melanoma in Poland. An association between malignant melanoma and breast cancer has been reported in several families with CDKN2A mutations, Objective: To determine whether this variant also predisposes to breast cancer. Methods: Genotyping was undertaken in 4209 cases of breast cancer, unselected for family history, from 18 hospitals throughout Poland and in 3000 controls. Results: The odds ratio ( OR) associated with the CDKN2A allele for women diagnosed with breast cancer before the age of 50 was 1.5 ( p = 0.002) and after age 50 it was 1.3 ( p = 0.2). The effect was particularly strong for patients diagnosed at or before the age of 30 ( OR = 3.8; p = 0.0002). Conclusions: CDKN2A appears to be a low penetrance breast cancer susceptibility gene in Poland. The association should be confirmed in other populations.

引用

页码：763 / 765

页数：3

共 26 条

[1] CDKN2A variants in a population-based sample of queensland families with melanoma [J].

Aitken, J ;

Welch, J ;

Duffy, D ;

Milligan, A ;

Green, A ;

Martin, N ;

Hayward, N .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (05) :446-452

[2] Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis [J].

Belinsky, SA ;

Nikula, KJ ;

Palmisano, WA ;

Michels, R ;

Saccomanno, G ;

Gabrielson, E ;

Baylin, SB ;

Herman, JG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11891-11896

[3] An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele [J].

Bertram, CG ;

Gaut, RM ;

Barrett, JH ;

Pinney, E ;

Whitaker, L ;

Turner, F ;

Bataille, V ;

Silvaj, ID ;

Swerdlow, AJ ;

Bishop, DT ;

Bishop, JAN .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (04) :961-965

[4] High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families [J].

Borg, Å ;

Sandberg, T ;

Nilsson, K ;

Johannsson, O ;

Klinker, M ;

Måsbäck, A ;

Westerdahl, J ;

Olsson, H ;

Ingvar, C .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (15) :1260-1266

[5] Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer [J].

Burri, N ;

Shaw, P ;

Bouzourene, H ;

Sordat, I ;

Sordat, B ;

Gillet, M ;

Schorderet, D ;

Bosman, FT ;

Chaubert, P .

LABORATORY INVESTIGATION, 2001, 81 (02) :217-229

[6] CHEK2 is a multiorgan cancer susceptibility gene [J].

Cybulski, C ;

Górski, B ;

Huzarski, T ;

Masojc, B ;

Mierzejewski, M ;

Debniak, T ;

Teodorczyk, U ;

Byrski, T ;

Gronwald, J ;

Matyjasik, J ;

Zlowocka, E ;

Lenner, M ;

Grabowska, E ;

Nej, K ;

Castaneda, J ;

Medrek, K ;

Szymanska, A ;

Szymanska, J ;

Kurzawski, G ;

Suchy, J ;

Oszurek, O ;

Witek, A ;

Narod, SA ;

Lubinski, J .

AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (06) :1131-1135

[7]

Debniak T, 2005, CANCER RES, V65, P835

[8] Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer [J].

Debniak, T ;

Gorski, B ;

Scott, RJ ;

Cybulski, C ;

Medrek, K ;

Zlowocka, E ;

Kurzawski, G ;

Debniak, B ;

Kladny, J ;

Bielecka-Grzela, S ;

Maleszka, R ;

Luminski, J .

INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (04) :558-562

[9]

Ghiorzo P, 1999, INT J CANCER, V83, P441, DOI 10.1002/(SICI)1097-0215(19991112)83:4<441::AID-IJC2>3.0.CO

[10]

2-R

← 1 2 3 →